Abstract
Abstract Background Heart failure (HF) is associated with cardiomyocyte (CM) telomere shortening. Sequelae have been described with the telomere-p53-mitochondrion model. P53 deficiency only partially ameliorates mitochondrial defects in telomerase deficient mice hinting at additional pathways. Purpose We assessed the cardiac phenotype and transcriptome of early/advanced telomere shortening and evaluated the pathological relevance by correlation to published HF datasets. Methods Male (6-8w) telomerase RNA-component deficient mice, early (generation 2, mTRG2) and advanced (mTRG5) were phenotyped vs age-matched C57BL/6 mice (B6). Adult CMs from mTRG2/G5 vs B6 mice were characterized (live imaging, quantitative fluorescence in situ hybridization (Q-FISH) and transcriptome analysis (microarray Mouse MTA 1.0)). Gene expression analysis was performed (Ingenuity Pathway Analysis, Qiagen) and correlated to comparable datasets from > 120 000 curated datasets. Results CMs exhibited significant telomere shortening in mTR(-/-) mice increasing with every generation (mTRG2/G5 p<0.0001 vs B6). In parallel, echocardiography revealed increasing defects of left ventricular (LV) systolic function (LVEF, mTRG5 <0.01 vs B6), LV global longitudinal strain mTRG2/G5 p<0.001 vs B6) and LV contractile reserve (mTRG2/G5 p<0.05 vs B6). Live imaging showed increasing impairment of mitochondrial polarization with all energy substrates (mTRG2/G5 p<0.0001 vs B6). Transcriptome analysis revealed 357/2906 differentially expressed genes (DEGs) in mTRG2/G5-CMs vs B6-CMs (fold change <-1.5 or >1.5 and p-value <0.05). Upstream Regulator (UR) analysis revealed significant overrepresentation of numerous regulators including angiotensinogen (z-score 7.5, p-value 1.1E-32), transforming growth factor (TGF)-b1 (z-score 7.5, p-value 2.2E-60), interleukin (IL)-1 (z-score 5.6, p-value 1.1E-26), IL-6 (expression fold change 11.3, z-score 6.9 p-value 2.65E-32), IL-17A (z-score 4.8, p-value 4.4E-27) and NFkB (z-score 6.0 p-value 4.9E-19). Activation of TP53 (z-score 5.8, p-value 5.3E-31) and inhibition of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PPARGC1A) (z-score -4.4, p-value 6.3E-19) confirmed the relevance of the p53-mitochondrion-axis. Analysis matching revealed a significant overlap of gene expression patterns in the same direction (positive z-score) between mTR-/--mice and all comparable datasets of dilated (DCM) and ischemic cardiomyopathy (ICM) (human/mouse), the overlap increasing with increasing telomere shortening (e.g. DCM vs mTRG2: z-score 17.7, UR p-value 1.5E-16; DCM vs mTRG5: z-score 56.8, UR-value 1.5E-62). Matching to datasets after cardiac regeneration (e.g. after left ventricular assist device implantation) revealed a reversal of gene expression patterns (negative z-score). Conclusions Our results reveal the large extent of transcriptional alterations upon cardiac telomere shortening and support their central role in the pathogenesis of HF.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call